Showing results (11-20 of 768) with videos related to
Sort By:
Pageof 77
The American Journal of Psychiatry|October 1, 1993
Polydipsia and tardive dyskinesia in chronic psychiatric patients--related disorders?D S Umbricht, B Saltz, S Pollack, et al.The New England Journal of Medicine|July 15, 1993
Clozapine-induced agranulocytosis. Incidence and risk factors in the United StatesJ M Alvir, J A Lieberman, A Z Safferman, et al.Advances in Neurology|January 1, 1986
Neuromuscular effects of monoamine oxidase inhibitorsJ A Lieberman, J M Kane, R ReifePsychopharmacology|January 1, 1987
Provocative tests with psychostimulant drugs in schizophreniaJ A Lieberman, J M Kane, J AlvirJournal of Clinical Psychopharmacology|August 1, 1985
Neuromuscular effects of monoamine oxidase inhibitorsJ A Lieberman, J M Kane, R ReifeSchizophrenia Bulletin|January 1, 1991
A selective review of biological markers in schizophreniaS Szymanski, J M Kane, J A LiebermanThe Journal of Clinical Psychiatry|September 1, 1989
Clozapine: guidelines for clinical managementJ A Lieberman, J M Kane, C A JohnsThe Journal of Clinical Psychiatry|September 1, 1994
Clozapine and weight gainD S Umbricht, S Pollack, J M KaneArchives of General Psychiatry|October 1, 1989
Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategyJ A Lieberman, J Alvir, S Mukherjee, et al.The Annals of Pharmacotherapy|March 1, 1992
Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case reportA Z Safferman, S J MasiarPageof 77